Sodium Phosphate, Dibasic

60 interactions 4 explained in plain English
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Burosumab-Twza Injection Levofloxacin Injection Oxaliplatin Injection Alfuzosin Goserelin Implant Arsenic Trioxide
1 Contraindicated 58 Major 1 Moderate
All (60) Contraindicated (1) Major (58) Moderate (1)

Major

Sodium Phosphate, Dibasic Lenvatinib Lenvima Increased risk of QT-interval prolongation Details Sodium Phosphate, Dibasic Levofloxacin Levaquin Increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Levofloxacin Injection Levaquin Increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Loperamide Diamode An increased risk of QT interval prolongation, which may increase risk of cardiotoxicity (torsade de pointes, cardiac arrest) Details Sodium Phosphate, Dibasic Mefloquine Lariam® An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Metronidazole Flagyl An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Metronidazole Injection Flagyl An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Metronidazole Topical MetroCream® An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Metronidazole Vaginal MetroGel® Vaginal An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Moxifloxacin Avelox Increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Moxifloxacin Injection Avelox Increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Moxifloxacin Ophthalmic Moxeza® Increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Octreotide Bynfezia An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Octreotide Injection Bynfezia An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Ofloxacin Floxin® An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Ofloxacin Ophthalmic Ocuflox An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Ofloxacin Otic Floxin® Otic An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Olodaterol Oral Inhalation Striverdi An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Sodium Phosphate, Dibasic Oxaliplatin Injection Eloxatin® Increased risk of QT-interval prolongation Details

Moderate

Sodium Phosphate, Dibasic Colestipol Colestid Decreased phosphate absorption Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.